IKK1 kinase coordinates BRD4 and JAK/STAT signaling to subvert DNA damage-based anticancer therapy
Espinosa, L.; Pecharroman Ruiz, I.; Sole, L.; Alvarez-Villanueva, D.; Lobo, T.; Alonso, J.; Bertran, j.; Sabido, E.; Borras, E.; Garcia-Hernandez, V.; garrido, M.; Seoane, J.; Bigas, A.; Villanueva, A.; Martinez-Iniesta, M.; Bonfill, E.; Iurlaro, R.; Santos, C.; Guillen, Y.; Montoto, A.; Gimenez, G.; Iglesias, M.; salazar, R.
Show abstract
Activation of the IKK kinase complex has recurrently been linked to colorectal cancer (CRC) initiation and progression. However, identification of downstream effectors other than NF-{kappa}B has remained elusive. Analysis of IKK-dependent substrates after UV-treatment revealed that BRD4 phosphorylation by IKK is required for chromatin-binding dynamics upon damage. Moreover, IKK induces the NF-{kappa}B-dependent transcription of LIF leading to STAT3 activation, association of BRD4 to STAT3 and recruitment to specific target genes. IKK abrogation results in defective BRD4 and STAT3 function leading to irreparable DNA damage and apoptotic cell death upon different stimuli. Simultaneous inhibition of BRAF-dependent IKK activity or BRD4 and the JAK/STAT pathway enhanced the therapeutic potential of 5-FU plus irinotecan in CRC cells, and is curative in a chemotherapy-resistant CRC xenograft model. Coordinated expression of LIF and IKK is a poor prognosis marker for CRC patients. Our data uncover a functional link between IKK, BRD4 and JAK/STAT signaling with clinical relevance.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription 97%
- Suppression of HSF1 activity by wildtype p53 creates the driving force for p53 loss-of-heterozygosity, enabling mutant p53 stabilization and invasion 96%
- An integrative oncogene-dependency map identifies unique vulnerabilities of oncogenic EGFR, KRAS, and RIT1 in lung cancer 96%
Similar papers in this journal
- Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification 96%
- The tRNA Gm18 Methyltransferase TARBP1 Promotes Hepatocellular Carcinoma Progression via Metabolic Reprogramming of Glutamine 95%
- The kinase domain of RIPK3 tunes its scaffolding functions 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.